Clinical Drug Experience Knowledgebase

apaziquone (1 trial)

carboplatin (paraplatin) (4 trials)

cisplatin (platinol) (2 trials)

cyclophosphamide (cytoxan) (7 trials)

docetaxel (taxotere) (6 trials)

efaproxiral sodium (4 trials)

eflapegrastim (Rolvedon) (5 trials)

eoquin (6 trials)

filgrastim (neupogen) (6 trials)

gemcitabine (gemzar) (2 trials)

ibritumomab tiuxetan (zevalin) (10 trials)

nt0102 (1 trial)

oxygen (1 trial)

ozarelix (3 trials)

paclitaxel (taxol) (4 trials)

poziotinib (11 trials)

pralatrexate (folotyn) (15 trials)

prednisone (meticorten) (3 trials)

rituximab (rituxan) (10 trials)

secretin human (chirhostim) (6 trials)

vincristine (oncovin) (15 trials)

vinorelbine (navelbine) (2 trials)

allogeneic hematopoietic stem cells (Hemacord) (1 trial)

Anti-thymocyte Globulin (Rabbit) (Thymoglobulin) (2 trials)

belinostat (beleodaq) (12 trials)

bendamustine (treanda) (3 trials)

bortezomib (velcade) (2 trials)

clofarabine (clolar) (1 trial)

cyanocobalamin (berocca) (8 trials)

cyclosporine (sandimmune) (1 trial)

cytarabine (cytosar-u) (3 trials)

doxorubicin (Doxil) (3 trials)

elsamitrucin (2 trials)

erlotinib (tarceva) (1 trial)

etoposide (vepesid) (2 trials)

fludarabine (fludara) (1 trial)

fludeoxyglucose f-18 (1 trial)

folic acid (8 trials)

goserelin (zoladex) (1 trial)

ign002 (2 trials)

imatinib (gleevec) (1 trial)

leteprinim potassium (1 trial)

leucovorin (1 trial)

lucanthone hydrochloride (2 trials)

melphalan (alkeran) (5 trials)

mercaptopurine (purinethol) (1 trial)

mesna (mesnex) (1 trial)

methylprednisolone (medrol) (1 trial)

mitoxantrone (novantrone) (1 trial)

motexafin gadolinium (1 trial)

mycophenolate (myfortic) (2 trials)

naltrexone (revia) (3 trials)

nelarabine (arranon) (1 trial)

palifermin (kepivance) (1 trial)

panobinostat (farydak) (1 trial)

pegaspargase (oncaspar) (1 trial)

peripheral blood hematopoietic cell (1 trial)

sargramostim (leukine) (2 trials)

sovateltide (3 trials)

stem cells (1 trial)

tacrolimus (prograf) (1 trial)

talotrexin (3 trials)

temozolomide (temodar) (2 trials)

urea (4 trials)

uridine (2 trials)

abatacept (orencia) (1 trial)

autologous hematopoietic cell (1 trial)

bexarotene (targretin) (1 trial)

ciprofloxacin (cipro) (1 trial)

fluconazole (diflucan) (1 trial)

itraconazole (sporanox) (1 trial)

levoleucovorin (fusilev) (2 trials)

paroxetine (paxil) (1 trial)

phenytoin (mesantoin) (1 trial)

renazorb (1 trial)

rg2133 (1 trial)

rh-1 (1 trial)

topotecan (hycamtin) (1 trial)

trastuzumab emtansine (kadcyla) (1 trial)

vitamin k3 sodium bisulfite (synkavite) (1 trial)

warfarin (coumadin) (1 trial)